The human peroxisome proliferator-activated receptor α gene: Identification and functional characterization of two natural allelic variants

Pharmacogenetics

Volumn 10, Issue 4, 2000, Pages 321-333

  Sapone, Andrea ^a   Peters, Jeffrey M ^a   Sakai, Shuichi ^a   Tomita, Shuhei ^a   Papiha, Surinder S ^b   Dai, Renke ^a   Friedman, Fred K ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Fibrate drugs; Transactivation; Transfection; Wy 14 643

Indexed keywords

DNA; DNA BINDING PROTEIN; LIGAND; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSFECTION; GENE FREQUENCY; GENE ISOLATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; TRANSACTIVATION;

EID: 0034046520     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200006000-00006     Document Type: Article

References (60)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389-3402.
2. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferalor-activated receptor alpha (PPARα). J Biol Chem 1998; 273:5678-5684.
3. Auwerx J, Martin G, Guerre-Millo M, Staels B. Transcription, adipocyte differentiation, and obesity. J Mol Med 1996a; 74:347-352.
4. Auwerx J, Schoonjans K, Fruchart JC, Staels B. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects. J Atheroscler Thromb 1996b, 3:81-89.
5. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995; 83:851-857.
6. Blaauboer BJ, van Holsteijn CW, Bleumink R, Mennes WC, van Pelt FN, Yap SH, et al. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem Pharmacol 1990; 40:521-528.
7. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997; 389:753-758.
8. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: structure and functions. Endocr Rev 1990; 11:201-220.
9. Cattley RC, DeLuca J, Elcombe C, Fenner-Crisp P, Lake BG, Marsman DS, et al. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 1998: 27:47-60.
10. de Wet JR, Woo KV, Deluca M, Helinski DR, Subramani S. Firefly luciferasc gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7:725-737.
11. Detera-Wadleigh SD, Fanning TG. Phylogeny of the steroid receptor superfamily. Mol Phylogenet Evol 1994; 3:192-205.
12. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice. J Clin Invest 1998; 102:1083-1091.
13. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992; 68:879-887.
14. Duclos S, Bride J, Ramirez LC, Bournot P. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate. Eur J Cell Biol 1997; 72:314-323.
15. Escriva H, Safi R, Hanni C, Langlois MC, Saumitou-Laprade P, Stehelin D, et al. Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 1997; 94:6803-6808.
16. Fernandez-Salguero P, Hoffman SM, Cholerton S, Mohrenweiser H, Raunio H, Rautio A. et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2 A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 1995; 57:651-660.
17. Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA-binding domain. Nature 1988; 334:543-546.
18. Gaw A, Packard CJ, Caslake MJ, Griffin BA, Lindsay GM, Thomson J, et al. Effects of ciprofibrate on LDL metabolism in man. Atherosclerosis 1994; 108:137-148.
19. Gearing KL, Crickmore A, Gustafsson JA. Structure of the mouse peroxisome proliferator-activated receptor alpha gene. Biochem Biophys Res Commun 1994; 199:255-263.
20. Gonzalez FJ, Peters JM, Cattley RC. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor α. J Natl Cancer Inst 1998; 90:1702-1709.
21. Gorla-Bajszczak A, Juge-Aubry C, Perin A, Burger AG, Meier CA. Conserved amino acids in the ligand-binding and ti domains of the peroxisome proliferator-activated receptor α are necessary for heterodimerization with RXR. Mol Cell Endocrinol 1999; 147:37-47.
22. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2:1044-1051.
23. Gottlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 1992: 89:4653-4657.
24. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52:456-467.
25. Holden PR, Tugvvood JD. Peroxisome proliferator-activated receptor α: role in rodent liver cancer and species differences. J Mol Endocrinol 1999; 22:1-8.
26. Hsu MH, Palmer CN, Griffin KJ, Johnson EF: A single amino acid change in the mouse peroxisome proliferator-activated receptor α alters transcriptional responses to peroxisome proliferators. Mol Pharmacol 1995; 48:559-567.
27. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347:645-650.
28. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 1995; 83:859-869.
29. Lake BG. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu Rev Pharmacol Toxicol 1995; 35:483-507.
30. Laudet V. Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J Mol Endocrinol 1997; 19:207-226.
31. Lee MS, Kliewer SA, Provencal J, Wright PE, Evans RM. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. Science 1993; 260:1117-1121.
32. Lee MS, Sem DS, Kliewer SA, Provencal J, Evans RM, Wright PE: NMR assignments and secondary structure of the retinoid X receptor alpha DNA-binding domain. Evidence for the novel C-terminal helix. Eur J Biochem 1994; 224:639-650.
33. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15:3012-3022.
34. Lee SS, Gonzalez FJ. Targeted disruption of the peroxisome proliferator-activated receptor α gene, PPARα. Ann NY Acad Sci 1996; 804:524-529.
35. Luisi BF, Xu WX, Otwinoski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991; 352:497-505.
36. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83:841-850.
37. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835-839.
38. Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 1998; 10:384-391.
39. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue-and inducer-specific manner. J Biol Chem 1998; 273:16710-16714.
40. Myers KA, Lambe KG, Aldridge TC, Macdonald N, Tugwood JD. Amino acid residues in both the DNA-binding and ligand-binding domains influence transcriptional activity of the human peroxisome proliferator-activated receptor α. Biochem Biophys Res Commun 1997; 239:522-526.
41. Peters JM, Cattley RC, Gonzalez FJ. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14 643. Carcinogenesis 1997a; 18:2029-2033.
42. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, et al. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 1997b: 272:27307-27312.
43. Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, Gonzalez FJ. Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver. Carcinogenesis 1998; 19: 1989-1994.
44. Rao MS, Reddy JK. Hepatocarcinogenesis of peroxisome proliferators. Ann NY Acad Sci 1996; 804:573-587.
45. Rastinejad F, Perlmann T, Evans RM, Sigler PB. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995; 375:203-211.
46. Reddy JK, Mannaerts GP: Peroxisomal lipid metabolism. Annu Rev Nutr 1994; 14:343-370.
47. Reddy JK, Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann NY Acad Sci 1996; 804:176-201.
48. Robberson BL, Cote GJ, Berget SM. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol Cell Biol 1990; 10:84-94.
49. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 1992; 6:1634-1641.
50. Sem DS, Casimiro DR, Kliewer SA, Provencal J, Evans RM, Wright PE. NMR spectroscopic studies of the DNA-binding domain of the monomer-binding nuclear orphan receptor, human estrogen related receptor 2. The carboxyl-terminal extension to the zinc-finger region is unstructured in the free form of the protein. J Biol Chem 1997; 272:18038-18043.
51. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987; 15:7155-7174.
52. Sher T, Yi HF, McBride OW, Gonzalez FJ. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 1993; 32:5598-5604.
53. Shows TB, McAlpine PJ, Boucheix C, Collins FS, Conneally PM, Frezal J, et al. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN 1987). Cytogenet Cell Genet 1987; 46:11-28.
54. Thummel CS. From embryogenesis to metamorphosis: the regulation and function of Drosophila nuclear receptor superfamily members. Cell 1995; 83:871-877.
55. Tugwood JD, Aldridge TC, Lambe KG, Macdonald N, Woodyatt NJ. Peroxisome proliferator-activated receptors: structures and function. Ann NY Acad Sci 1996; 804:252-265.
56. Tugwood JD, Holden PR, James NH, Prince RA, Roberts RA. A peroxisome proliferator-activated receptor-α (PPAR α) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPAR α: implications for species differences in responses to peroxisome proliferators. Arch Toxicol 1998; 72:169-177.
57. Umesono K, Evans RM. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989; 57:1139-1146.
58. Uppenberg J, Svensson C, Jaki M, Bertilsson G, Jendeberg L, Berkenstam A. Crystal structure of the ligand-binding domain of the human nuclear receptor PPARγ. J Biol Chem 1998; 273:31108-31112.
59. Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AY, Reddy JK. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem 1996; 271:2147-2155.
60. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986; 324:641-646.